Evidence map›Paper›PMID 34970261›Full record

ArticleFrontiers in immunology2021

Chrysanthi Tsamadou, Daphne Engelhardt, Uwe Platzbecker, Elisa Sala, Thomas Valerius, Eva Wagner-Drouet, Gerald Wulf, Nicolaus Kröger, Niels Murawski, Hermann Einsele and 13 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Medicina (Kaunas, Lithuania) · 2024
    Article
  7. Article
  8. HLA Genetics for the Human Diseases.Advances in experimental medicine and biology · 2024
    Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Chrysanthi TsamadouInstitute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg - Hessen, and University Hospital Ulm, Ulm, Germany.
Daphne EngelhardtInstitute of Transfusion Medicine, University of Ulm, Ulm, Germany.
Uwe PlatzbeckerDepartment of Hematology/Oncology, University of Leipzig, Leipzig, Germany.
Elisa SalaDepartment of Internal Medicine III, University of Ulm, Ulm, Germany.
Thomas ValeriusSection for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian Albrechts University, Kiel, Germany.
Eva Wagner-DrouetDepartment of Medicine III, Johannes Gutenberg-University, Mainz, Germany.
Gerald WulfDepartment of Hematology/Oncology, Georg-August-University, Göttingen, Germany.
Nicolaus KrögerDepartment of Stem Cell Transplantation, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Niels MurawskiDepartment of Internal Medicine I, Universitätsklinikum des Saarlandes, Homburg, Germany.
Hermann EinseleDepartment of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
Kerstin Schaefer-EckartMedical Clinic 5: Hematology, Oncology, Nuremberg Hospital, Nuremberg, Germany.
Sebastian FreitagDepartment of Medicine III, Hematology/Oncology/Palliative Care, Rostock University Medical Center, Rostock, Germany.
Jochen CasperDepartment of Oncology and Hematology, Klinikum Oldenburg, University Clinic, Oldenburg, Germany.
Martin Kaufmann2nd Department of Internal Medicine, Oncology and Hematology, Robert Bosch Hospital, Stuttgart, Germany.
Mareike DürholtHematology/Oncology, Evangelic Clinic Essen-Werden, Essen-Werden, Germany.
Bernd HertensteinHematology/Oncology, Klinikum Bremen-Mitte, Bremen, Germany.
Stefan KleinUniversitätsmedizin Mannheim, Med. Klinik III, Mannheim, Germany.
Mark RinghofferMedizinische Klinik III, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
Sandra FrankDRST -Deutsches Register für Stammzelltransplantationen, German Registry for Stem Cell Transplantation, Ulm, Germany.
Christine NeuchelInstitute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg - Hessen, and University Hospital Ulm, Ulm, Germany.
Hubert SchrezenmeierInstitute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg - Hessen, and University Hospital Ulm, Ulm, Germany.
Joannis MytilineosDRST -Deutsches Register für Stammzelltransplantationen, German Registry for Stem Cell Transplantation, Ulm, Germany.
Daniel FuerstInstitute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg - Hessen, and University Hospital Ulm, Ulm, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

Hematopoietic Stem Cell TransplantationAdolescentAdultAgedChildChild, PreschoolDonor SelectionGermanyGraft vs Host DiseaseHematologic NeoplasmsHistocompatibility TestingHLA-DRB3 ChainsHLA-DRB4 ChainsHLA-DRB5 ChainsHumansInfantHLA-DRB3 ChainsHLA-DRB4 ChainsHLA-DRB5 ChainsDRB3/4/5 matchingHLA-DRB3HLA-DRB3/4/5HLA-DRB4HLA-DRB5HLA-matchedunrelated hematopoietic stem cell transplantation (uHSCT)

Identifiers

PMID34970261
PMCPMC8712639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.